Aims: Dracocephalum kotschyi Boiss is a flowering plant that the biological activities of the declared species D. kotschyi such as a warm herbal medicine for rheumatoid diseases, headaches, congestion, stomach disorders, liver treatment, and other usages. The current study aims to investigate the chemical composition, genotoxicity, and antimicrobial activity of Dracocephalum kotschyi Boiss against OXA-48 producing K. pneumoniae isolated in Kurdistan province, Iran. Shakib et al.; MRJI, 24(3): 1-8, 2018; Article no.MRJI.42064 2 Methodology: Fourteen OXA-48 producing K. pneumoniae were isolated by the PCR assay from major hospitals in Kurdistan province, Iran. GC-MS examination, and in vitro antimicrobial and genotoxicity activities of this essential oil was studied. The data was analyzed using SPSS software and ANOVA. Results: Out of 70 K. pneumoniae clinical strains, 14 OXA-48 producing K. pneumoniae were isolated by the PCR assay. The chemical composition of the oils contained Monoterpene Hydrocarbons, Oxygenated Monoterpenes, Sesquiterpene Hydrocarbons, and Oxygenated Sesquiterpenes. D. kotschyi essential oils showed antimicrobial activity against all of the tested strains, with inhibition values varying from >5000 to 1250 μg/ml for MIC and >5000 μg/ml for MBC in bacteria. In the Ames test, D. kotschyi had a strong anti-mutagenesis effect. Conclusion: According to the findings of the current study, it can be concluded that D. kotschyi essential oils could be applied as a safe antibacterial agent for treatment of OXA-48 producing K. pneumoniae.
INTRODUCTION
Klebsiella pneumoniae is an opportunistic pathogen that causes infections in the urinary tract (UTI) and respiratory systems, and can result in systemic infections [1, 2] . Carbapenems are one type of antibiotics that are used for treatment of K. pneumoniae infections [3] . Currently, carbapenem resistance in K. pneumoniae isolates is growing and is generating a great concern [2] . Carbapenem resistance is created by many mechanisms such as upregulation of efflux pumps or loss of porins, and existence of carbapenem-hydrolyzing enzymes (carbapenemases) [4] . Oxa-48-type carbapenemase class D β-lactamases are generally spread among K. pneumoniae [5] . Currently, different approaches are applied in order to control antibiotic-resistant pathogens, including medicinal plants that are being used for treatment of various pathogens [6] .
Dracocephalum kotschyi Boiss is a flowering plant that belongs to the Labiateae family, floating fragments of D. kotschyi are original of essential oils and flavonoids [7] . D. kotschyi is native to Iran and grows in several provinces, including Lorestan, Golestan, Fars, Mazandaran, Hamadan, and Tehran. Some studies have conducted to research the biological activities of the declared species [8, 9] . In traditional medicine, D. kotschyi is applied as a warm herbal medicine for rheumatoid diseases, headaches, congestion, stomach disorders, liver treatment, and other usages that are described for D. kotschyi [7, 10, 11] . There is no report of the antimicrobial activity of this plant against OXA-48 producing K. pneumoniae in Pub Med and Google Scholar. Therefore, the present study is aimed to investigate the chemical composition, 
METHODOLOGY

Plant Material
Flowering fragments of D. kotschyi Boiss were collected from Ashrafi project [9] . D. kotschyi Boiss was collected from the Garin Mountain in Lorestan province, Iran, by Ashrafi et al.
Analysis of the Essential Oil
Gas chromatography -mass spectrometry (GC-MS) analysis was carried out in an Agilent 6890 gas chromatograph interfaced with an Agilent 5973 MSD, applying helium as the carrier gas (0.9 ml/min, and the same capillary column previously mentioned). The column temperature was raised from 50 (hold 3 min) to 180ºC at the rate of 5ºC/min and up to 240ºC at 10ºC/min rate; and then the temperature was kept stable for an additional 20 min at 280ºC. The injector and detector temperatures were 200 and 280ºC, respectively. A 0.3-μl sample was injected using the split mode [12]. 
Microbial
Minimum Inhibition Concentration (MIC) and Minimal Bactericidal Concentration (MBC)
By using 96-well microtiter plates and utilizing the broth microdilution method, the minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were determined. In a typical procedure, the bacterial strains were cultured overnight at 37°C on Muller-Hinton agar adjusted to a final density of 8 log CFU/mL, which were used to inoculate (1-10) 96-well microtiter plates containing the serial dilutions of the essential oils (5120-20 μg/ml) on MHB. A positive control containing the bacterial culture and broth without the plant oils was included in each test. The contents of each well were incubated at 37°C for 24 h. Then, 2, 3, 5-triphenyltetrazolium chloride was used for visual indication of bacterial growth. The MIC of the essential oils was regarded as the lowest concentration that showed zero growth [15] . All the samples that showed no turbidity were subcultured; however, the lowest concentration, from which the microorganisms did not recover was the minimal bactericidal concentration (MBC). Each experiment was performed in triplicate [15].
Disc Diffusion Assay
Antibacterial activity of D. kotschyi was assessed by the well diffusion assay (NCCLS, 1993). Discs containing imipenem and DMSO 10% were used as positive and negative controls respectively; then, plates were incubated at 37°C for 24 h. Antimicrobial activity was determined by measuring the inhibition zone against the tested clinical isolates [16] .
Ames Test, Media Preparation
The Ames test was carried out by glucose minimum agar (10% glucose), Top agar with 0.005 mM Biotin-Histidine and nutrient broth (Merck, Germany), and Salmonella typhimurium TA100 isolate. The strain had histidine mutation in the histidine operon [17] .
Statistical Analysis
All the experiments were repeated three times. The data was analyzed by SPSS software program, version 18, using ANOVA with the least significant difference (LSD) at the 0.05 probability level.
RESULTS
Microbial Strains, DNA Extraction and PCR-Amplifications of OXA-48 Gene
Out of 70 K. pneumoniae clinical isolates, 14 OXA-48 producing K. pneumoniae were isolated by the PCR assay from different general hospitals of Kurdistan Province of Iran. 
Analyses of the Essential Oils
The Mass chromatogram of D. kotschyi essential oil is shown in Fig. 2 and chemical composition of the oils is listed in Table 1 . The retention indices for each compound are also presented in Table 1 . 
Antimicrobial Activity of the Essential Oil
The antimicrobial activities of D. kotschyi against oxa-48 producing K. pneumoniae are investigated in the present study by in vitro microbiological techniques including the minimum inhibitory concentrations (MICs), minimum bactericidal concentration (MBC), and disc diffusion assay. MIC and MBC were determined by the broth micro-dilution method and the results are listed in Table 2 . D. kotschyi showed antimicrobial activities against 14 oxa-48 producing isolates, with inhibition values varying from >5000 to 1250 μg/ml for MIC and >5000 μg/ml for MBC in bacteria [18] .
Considering the radius of the inhibition zones, essential oils exhibited weak antibacterial activity against OXA-48 producing isolates, with a 10.40 ± 0.05 mm zone of inhibition. The detected antibacterial properties of the essential oils against various bacteria were different, ranging from strong antibacterial activity (inhibition zone ˃ 20 mm) to moderate activity (inhibition zone < 12-20 mm) and even no inhibition (zone < 12 mm) [19] .
Genotoxicity Activity of the Essential Oil
Results of the Ames test in this study, showed that inhibition percentage of D. kotschyi was 65, 37, and 19% in 5000, 2500, and 1250 (µg/ml) respectively (Table 3) . Inhibition percentages were evaluated by the formula presented by Ong et al. in 1986 [20] . According to the analyses, significant differences were observed between all the treatments (S9-) compared to the control group (P<0.05). A significant difference was observed between 5000(µg/ml) in comparison with the control group (S9+) (P<0.05). A significant difference was observed between 5000 (µg/ml) compared to 2500 (µg/ml) treatment (S9+) (P<0.05). A significant difference was observed between 2500 (µg/ml) in comparison with the control group (S9+) (P<0.05). A significant difference was observed between 2500(µg/ml) compared to 1250(µg/ml) treatment (S9+) (P<0.05). No significant difference was observed between 1250(µg/ml) compared to the control group (S9+) (P>0.05).
DISCUSSION
OXA-48 carbapenemase in Klebsiella pneumoniae was first defined in Turkey, then in several European countries such as France, and then in Middle Eastern countries including Lebanon and Kuwait, and afterwards in India and North Africa [21] [22] [23] [24] . In this study, 14 OXA-48 positive clinical strains were isolated from different general hospitals of Kurdistan province of Iran. Carbapenemase strains are one of the main concerns in treatments because they are resistant to most antibiotics that are currently being used [5] . In recent decades, essential oils are used as an alternative to antibiotics for treatment of many drug-resistant bacterial infections [6] . Accordingly to this, the aim of our study was evaluate antimicrobial activities of Dracocephalum kotschyi Boiss against OXA-48 [26] .
In the present study, TA100 S. typhimurium strain was used; and results of the Ames test showed that inhibition percentage of D. kotschyi was 65, 37, and 19% in 5000, 2500, and 1250 (µg/ml) respectively. The anti-mutagenesis effect had three levels of weak, moderate, and strong, which were considered to be less than 25%, between 25% and 40%, and above 40%, respectively. According to the results, D. kotschyi had strong anti-mutagenesis effect, and also Ashrafi et al. described that D. kotschyi had a high anti-oxidant activity [9] .
We showed for the first time antimicrobial and anti-mutagenesis activities of D. kotschyi against OXA-48 producing Klebsiella pneumoniae clinical isolates.
Yahiaoui et al. showed that mentha pulegium essential oil effect on ESBL producing bacteria and described prospective synergistic effects with conventional antibiotics such as amoxicillin [27] , also we demonstrated D. kotschyi effect on OXA-48 producing isolates.
CONCLUSION
In conclusion, result presented here may suggest that D. kotschyi can be used as an alternative antibiotic drug to treat infections caused by OXA-48 producing K. pneumoniae isolates. Recently, OXA-48 producing K. pneumoniae isolates have been prevalent in hospitals and treatment centers, and they are resistant to many antibiotics. In addition, another feature of D. kotschyi to be mentioned is that it is safe for humans due to its anti-mutagenesis effect against TA100 S. typhimurium.
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